Tag: cancer

What do the IARC’s carcinogen classifications actually mean?

Infographic on the IARC carcinogen classification system. Classifications are shown along with example substances that fall within each category. Classifications range from group 1 (carcinogenic to humans) to group 4 (probably not carcinogenic).

Alcohol: Well known to be carcinogenic to humans. Despite this, a large proportion of the population drink it regularly. More surprisingly, whenever the International Agency for Research on Cancer updates its carcinogen classifications for other substances with a lower cancer risk, there’s often media fanfare. In recent years, the IARC has upgraded classifications for red meat and aspartame, leading to a spate of panicked articles. This republished and updated post takes a look at what the classification groups actually mean, and how worried we should be about a substance’s classification.

Read more
2018 Nobel Prize Physiology-Medicine

The 2018 Nobel Prize in Physiology/Medicine: Unleashing our immune systems against cancer

[fusion_builder_container hundred_percent=”yes” overflow=”visible”][fusion_builder_row][fusion_builder_column type=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”no” center_content=”no” min_height=”none”]

2018 Nobel Prize Physiology-Medicine
Click to enlarge

Today saw the first of the 2018 Nobel Prizes awarded. The 2018 Nobel Prize in Physiology or Medicine was awarded to James P. Allison and Tasuku Honjo for their discovery of cancer therapy by stimulating the immune system to attack tumour cells. This graphic takes a look at the prize-winning research.

Read more
C&EN – Platinum drugs for cancer preview

40 years of platinum drugs for cancer – in C&EN

[fusion_builder_container hundred_percent=”yes” overflow=”visible”][fusion_builder_row][fusion_builder_column type=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”no” center_content=”no” min_height=”none”]

C&EN – Platinum drugs for cancer preview
Click to view full graphic on the C&EN site

2018 marks 40 years since the FDA first approved cisplatin, a platinum-containing drug to treat cancer. This month’s edition of Periodic Graphics in Chemical & Engineering News looks at how it works and some of the other platinum-containing drugs that followed. Click through to see the full version of the graphic on the C&EN site.

Read more